MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-07-2025
Establishment Labs Holdings DPO Ratio 2011-2026 | ESTA
Annual DPO Ratio Establishment Labs Holdings
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 279 | 193 | 114 | 107 | 114 | 109 | 90.8 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 279 | 90.8 | 144 |
Quarterly DPO Ratio Establishment Labs Holdings
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 271 | 287 | 302 | - | 198 | 179 | 259 | - | 195 | 111 | 112 | - | 115 | 108 | 105 | - | 98.2 | 82.4 | 83.3 | - | 117 | 274 | 102 | - | 110 | 109 | 79.5 | - | 92.2 | 104 | 102 | - | 224 | 92.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 302 | 79.5 | 150 |
DPO Ratio of other stocks in the Medical devices industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Allied Healthcare Products
AHPI
|
23.1 | - | 3.58 % | $ 2.21 M |  USA |
 |
Cognyte Software Ltd.
CGNT
|
81.1 | $ 7.25 | -8.17 % | $ 521 M |  Israel |
 |
GenMark Diagnostics, Inc.
GNMK
|
81.3 | - | - | $ 1.77 B | USA |
 |
Apollo Endosurgery
APEN
|
63.6 | - | - | $ 475 M | USA |
 |
Acutus Medical
AFIB
|
92.7 | - | -26.83 % | $ 2.62 M | USA |
 |
Lianluo Smart Limited
LLIT
|
10.5 | - | 24.59 % | $ 44.8 M |  China |
 |
Axonics Modulation Technologies
AXNX
|
40.1 | - | - | $ 3.31 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
224 | - | -5.86 % | $ 30.6 M | USA |
 |
Aziyo Biologics
AZYO
|
48.8 | - | 1.37 % | $ 20.5 M | USA |
 |
Apyx Medical Corporation
APYX
|
52.8 | $ 3.97 | - | $ 137 M | USA |
 |
Alphatec Holdings
ATEC
|
99.4 | $ 13.48 | -4.13 % | $ 1.93 B | USA |
 |
BIOLASE
BIOL
|
66.7 | - | -13.19 % | $ 166 K | USA |
 |
EDAP TMS S.A.
EDAP
|
40.6 | $ 4.08 | 0.37 % | $ 152 M |  France |
 |
Bio-Rad Laboratories
BIO
|
41 | $ 299.07 | -2.23 % | $ 8.44 B | USA |
 |
Bruker Corporation
BRKR
|
46.4 | $ 41.06 | -3.54 % | $ 6.12 K | USA |
 |
Boston Scientific Corporation
BSX
|
66 | $ 78.26 | 3.65 % | $ 115 B | USA |
 |
Abbott Laboratories
ABT
|
82.8 | $ 109.11 | 0.84 % | $ 190 B | USA |
 |
Conformis
CFMS
|
50.4 | - | - | $ 16.4 M | USA |
 |
CryoLife, Inc.
CRY
|
41.1 | - | -4.14 % | $ 702 M | USA |
 |
ClearPoint Neuro
CLPT
|
25.8 | $ 12.43 | -6.61 % | $ 336 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
204 | - | 1.15 % | $ 34.5 M | USA |
 |
CONMED Corporation
CNMD
|
60.6 | $ 40.63 | 1.75 % | $ 1.25 B | USA |
 |
Cardiovascular Systems
CSII
|
81.8 | - | 0.15 % | $ 844 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
131 | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
83.1 | - | - | $ 462 M | USA |
 |
Cutera
CUTR
|
57.2 | - | -10.19 % | $ 1.99 M | USA |
 |
Neovasc
NVCN
|
48.6 | - | - | $ 111 M |  Canada |
 |
Intersect ENT, Inc.
XENT
|
72.8 | - | - | $ 955 M | USA |
 |
Dynatronics Corporation
DYNT
|
52.2 | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
124 | - | - | $ 10.2 M | USA |
 |
Electromed
ELMD
|
47.8 | $ 28.95 | -0.96 % | $ 245 M | USA |
 |
InMode Ltd.
INMD
|
65.1 | $ 14.77 | -1.66 % | $ 1.17 B | Israel |
 |
Second Sight Medical Products
EYES
|
21 | - | -0.97 % | $ 54.4 M | USA |
 |
Align Technology
ALGN
|
33.7 | $ 176.77 | 9.59 % | $ 13.2 B | USA |
 |
Avinger
AVGR
|
45.5 | - | -20.74 % | $ 369 K | USA |
 |
FONAR Corporation
FONR
|
16.6 | $ 18.54 | 0.11 % | $ 122 M | USA |
 |
Globus Medical
GMED
|
23.2 | $ 87.55 | 0.56 % | $ 11.9 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
43.8 | $ 10.94 | -1.26 % | $ 842 M | USA |
 |
IRIDEX Corporation
IRIX
|
50.7 | $ 1.45 | 0.69 % | $ 23.4 M | USA |
 |
IRadimed Corporation
IRMD
|
40.6 | $ 94.23 | 0.4 % | $ 1.19 B | USA |
 |
Integer Holdings Corporation
ITGR
|
31.9 | $ 85.94 | 0.49 % | $ 2.89 B | USA |
 |
Invacare Corporation
IVC
|
75.6 | - | - | $ 24.7 M | USA |
 |
Cytosorbents Corporation
CTSO
|
125 | $ 0.67 | 0.3 % | $ 36.5 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
70.1 | $ 16.64 | -1.54 % | $ 384 M | USA |